Common Stock, Shares, Issued of GT Biopharma, Inc. from Q4 2010 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
GT Biopharma, Inc. quarterly Common Stock, Shares, Issued history and change rate from Q4 2010 to Q3 2025.
  • GT Biopharma, Inc. Common Stock, Shares, Issued for the quarter ending 30 Sep 2025 was 6.05M shares, a 171% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

GT Biopharma, Inc. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 6.05M +3.82M +171% 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 3.27M +1.04M +46.5% 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 2.54M +1.16M +83.7% 31 Mar 2025 10-Q 15 May 2025
Q4 2024 2.23M +854K +61.8% 31 Dec 2024 10-Q 14 Nov 2025
Q3 2024 2.23M -39.2M -94.6% 30 Sep 2024 10-Q 14 Nov 2024
Q2 2024 2.23M -38.4M -94.5% 30 Jun 2024 10-Q 14 Aug 2024
Q1 2024 1.38M -35.5M -96.3% 31 Mar 2024 10-Q 15 May 2024
Q4 2023 1.38M +290K +26.6% 31 Dec 2023 10-K 21 Feb 2025
Q3 2023 41.4M +8.91M +27.4% 30 Sep 2023 10-Q 01 Nov 2023
Q2 2023 40.6M +9.95M +32.4% 30 Jun 2023 10-Q 07 Aug 2023
Q1 2023 36.9M +4.54M +14% 31 Mar 2023 10-Q 15 May 2023
Q4 2022 1.09M -31M -96.6% 31 Dec 2022 10-K 26 Mar 2024
Q3 2022 32.5M +2M +6.55% 30 Sep 2022 10-Q 31 Oct 2022
Q2 2022 30.7M +2.55M +9.06% 30 Jun 2022 10-Q 15 Aug 2022
Q1 2022 32.3M +11.8M +57.7% 31 Mar 2022 10-Q 16 May 2022
Q4 2021 32.1M +26.8M +514% 31 Dec 2021 10-K 30 Mar 2023
Q3 2021 30.5M -47M -60.6% 30 Sep 2021 10-Q 10 Nov 2021
Q2 2021 28.1M -47.3M -62.7% 30 Jun 2021 10-Q/A 29 Dec 2021
Q1 2021 20.5M -50.1M -70.9% 31 Mar 2021 10-Q 17 May 2021
Q4 2020 5.22M +1.11M +27.1% 31 Dec 2020 10-K 28 Mar 2022
Q3 2020 77.5M +10.6M +15.9% 30 Sep 2020 10-Q 13 Nov 2020
Q2 2020 75.4M +22.8M +43.3% 30 Jun 2020 10-Q/A 18 Aug 2020
Q1 2020 70.6M +19.2M +37.4% 31 Mar 2020 10-Q 15 May 2020
Q4 2019 4.1M -46.5M -91.9% 31 Dec 2019 10-K 16 Apr 2021
Q3 2019 66.9M +16.7M +33.2% 30 Sep 2019 10-Q 14 Nov 2019
Q2 2019 52.6M +2.53M +5.04% 30 Jun 2019 10-Q 14 Aug 2019
Q1 2019 51.4M 31 Mar 2019 10-Q 15 May 2019
Q4 2018 50.7M +533K +1.06% 31 Dec 2018 10-K 27 Mar 2020
Q3 2018 50.2M +460K +0.92% 30 Sep 2018 10-Q 14 Nov 2018
Q2 2018 50.1M +49.6M +9995% 30 Jun 2018 10-Q 14 Aug 2018
Q4 2017 50.1M +50M +47990% 31 Dec 2017 10-K 29 Mar 2019
Q3 2017 49.8M +21.5M +76.4% 30 Sep 2017 10-Q 14 Nov 2017
Q2 2017 496K -25.4M -98.1% 30 Jun 2017 10-Q 11 Aug 2017
Q1 2017 123M +101M +467% 31 Mar 2017 10-Q 28 Apr 2017
Q4 2016 104K -2.3M -95.7% 31 Dec 2016 10-K 01 Mar 2018
Q3 2016 28.2M -563M -95.2% 30 Sep 2016 10-Q/A 28 Feb 2018
Q2 2016 25.9M -566M -95.6% 30 Jun 2016 10-Q/A 28 Feb 2018
Q1 2016 21.7M -574M -96.4% 31 Mar 2016 10-Q/A 28 Feb 2018
Q4 2015 2.4M +33.4K +1.41% 31 Dec 2015 10-K/A 28 Feb 2018
Q3 2015 592M 0 0% 30 Sep 2015 10-Q 13 Nov 2015
Q2 2015 592M +18.7M +3.26% 30 Jun 2015 10-Q 14 Aug 2015
Q1 2015 596M +22.7M +3.96% 31 Mar 2015 10-Q 14 May 2015
Q4 2014 2.37M -571M -99.6% 31 Dec 2014 10-K/A 28 Feb 2018
Q3 2014 592M +18.7M +3.26% 30 Sep 2014 10-Q 08 Jan 2015
Q2 2014 573M 0 0% 30 Jun 2014 10-Q 08 Jan 2015
Q1 2014 573M 0 0% 31 Mar 2014 10-Q 08 Jan 2015
Q4 2013 573M +72.5M +14.5% 31 Dec 2013 10-K 31 Mar 2015
Q3 2013 573M +116M +25.3% 30 Sep 2013 10-Q 17 Dec 2014
Q2 2013 573M +209M +57.3% 30 Jun 2013 10-Q 12 Dec 2014
Q1 2013 573M +273M +90.8% 31 Mar 2013 10-Q 10 Dec 2014
Q4 2012 501M +231M +85.9% 31 Dec 2012 10-K 08 Jan 2015
Q3 2012 457M +219M +91.6% 30 Sep 2012 10-Q 21 Nov 2012
Q2 2012 364M +155M +73.9% 30 Jun 2012 10-Q/A 13 Sep 2012
Q1 2012 300M 31 Mar 2012 10-Q 21 May 2012
Q4 2011 269M +120M +80% 31 Dec 2011 10-K 18 Nov 2014
Q3 2011 239M 30 Sep 2011 10-Q 21 Nov 2011
Q2 2011 209M 30 Jun 2011 10-Q/A 12 Sep 2011
Q4 2010 150M 31 Dec 2010 10-K 16 Apr 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.